BBH

VanEck Vectors Biotech ETF
*Unless otherwise stated, data provided by FactSet.

BBH Fund Description

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

BBH Factset Analytics Insight

BBH offers a more concentrated take on the global biotech industry. Although the space is already dominated by US firms, the fund aims to select just 25 US listed companies by market cap, also weighing each constituent by market cap. The underlying index has a flexible definition of biotech, encompassing companies engaged primarily in research (including research contractors) and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment, excluding pharmacies. Also, despite capping its issuers to a maximum of 20%, the fund may still be top heavy due to the index’s concentrated nature. Overall, BBH is a viable take on this market. The index is reviewed semi-annually.

BBH MSCI ESG Analytics Insight

VanEck Vectors Biotech ETF has an MSCI ESG Fund Rating of A based on a score of 6.66 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. VanEck Vectors Biotech ETF ranks in the 65th percentile within its peer group and in the 96th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

BBH MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 08/03/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BBH 2.24% 9.94% 22.31% 26.45% 17.17% 12.54% --
BBH (NAV) 4.31% 12.96% 24.85% 25.97% 18.18% 12.88% --
MVIS US Listed Biotech 25 Index -- -- -- -- -- -- --
Thomson Reuters Global Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BBH Summary Data

VanEck
12/20/11
Open-Ended Fund
0.35%
$590.61M
$3.32M
0.10%

BBH Portfolio Data

$49.32B
77.32
7.43
0.37%
12/20/21
25

BBH Index Data

Market Cap
Market Cap
Thomson Reuters Global Biotechnology & Medical Research

BBH Portfolio Management

0.35%
-0.35%
-0.23%
-0.46%

BBH Tax Exposures

20.00% / 39.60%
0.04%
Qualified dividends
No

BBH Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

BBH Factset Analytics Block Liquidity

As of 08/04/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BBH. BBH is rated a 5 out of 5.

BBH Tradability

16,786
$3.32M
10,854
$2.18M
0.10%
$0.19
0.01%
0.62% / -1.03%
None
96.00%
25,000
0.43
0.00%
0.13%
219
$211.87
5

BBH Sector/Industry Breakdown


BBH
Segment Benchmark
65.94%
95.25%
20.53%
0.21%
9.10%
0.14%

BBH Countries


BBH
Segment Benchmark
92.09%
75.20%
4.05%
0.78%
3.86%
6.05%
--
0.32%
--
0.27%
--
0.36%
--
0.39%
--
0.02%
--
1.06%
--
0.03%

BBH Regions


BBH
Segment Benchmark
92.09%
75.52%
4.05%
12.66%
3.86%
11.78%
--
0.03%

BBH Economic Development


BBH
Segment Benchmark
100.00%
99.60%
--
0.40%

BBH Performance Statistics

0.83
0.99
1.01
0.99
0.58%
Thomson Reuters Global Biotechnology & Medical Research

BBH MSCI ESG Ratings

6.66 / 10
96.32
65.21
--
38.98%
19.57

BBH Benchmark Comparison Holdings

25
421
16
40.21%

BBH Benchmark Comparison Summary


BBH
Segment Benchmark
25
421
$49.32B
$30.04B
77.32
-57.79
7.43
6.55
0.46%
0.32%
High
Medium

BBH Benchmark Comparison Market Cap Size


BBH
Segment Benchmark
86.90%
53.50%
13.10%
27.93%
0.00%
15.12%
0.00%
3.45%